Pharmafile Logo

Establishing Remote Work Norms – Building Company Culture Virtually

Ready to redefine remote work in pharma? The second step is establishing clear norms, processes, and expectations that resonate with your team. Dive into our series for more tips on shaping a superior remote workplace in the life sciences industry today!

In the second video of our series on creating company culture in a virtual environment, we delve into the importance of establishing new norms, processes, and expectations for remote teams. Learn how involving team feedback can build a cohesive and productive remote work culture.

2. Create New Norms, Processes, Values, and Expectations for Your Remote Team Transitioning to remote work is like moving to a new house—it takes time to adjust and settle in. By allowing team members to explore what works best for them and integrating their feedback, leaders can develop clear and effective processes that everyone understands and supports. Establishing these norms not only helps in managing the team efficiently but also ensures that all members feel valued and involved. This collaborative approach fosters a sense of ownership and commitment, crucial for maintaining productivity and satisfaction in remote settings.

For more strategies on building a strong virtual company culture and to benefit from our extensive experience in remote team management, visit our blog: https://www.impetusdigital.com/2020/11/03/top-10-tips-for-creating-company-culture/

Enhance your remote team management skills with Impetus Digital:

Stay connected for more insights on remote work culture:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Biotech Innovation in the Time of COVID-19

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Using Technology to Improve Patient Experience

Dyan Bryson from Inspired Health Strategies discusses Patient Focused Drug Development, best practices for designing diverse and patient-centric trials, and how to use technology to improve the patient experience. She...

Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®

Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams.

Supporting Mental Health During a Global Pandemic

Sam Duboc, Chair & CEO of MindBeacon, explores virtual care and telehealth for treating depression, anxiety, addiction, and other conditions; mental health issues brought on by COVID-19; and how to...

Driving Digital Transformation in Healthcare Using AI

Tom Lawry, National Director for AI, Health & Life Sciences at Microsoft, shares how he helps life science companies implement innovative analytical solutions, the current barriers to enterprise-wide adoption of...

Blockchain in Healthcare: Predictions for the Post-COVID World

Dr. Jody Ranck, EVP, Global Strategy at Ram Global, discusses the novel ThEA diagnostic platform for rapid COVID-19 testing. He will also share his expertise on digital health, innovation, connected...

AI-Driven Customer Journey Mapping in Biopharma

Philip Poulidis (CEO & Co-founder) and Orchid Jahanshahi (VP, Life Sciences) from ODAIA explores AI and big data for customer journey mapping and dynamic segmentation, data integration, omni-channel customer engagement,...

Virtual MSL training on the Impetus InSite Platform®: A Customer Story

How a client used our award-winning virtual engagement and learning tools to produce a series of online training modules.

Digital Health for Improving Care in Disadvantaged Populations

Peter Wood (Co-founder & COO) and Dr. Raj Padwal (Co-founder & CEO) from mmHg Inc. explain how their Sphygmo virtual care system can be used to monitor blood pressure, glucose,...

The Future of Digital Pills

Valerie Sullivan, President and CEO at etectRx, dives into digital pills in healthcare and clinical research. Among many other things, we discuss how Pharma companies can benefit from the ability...